Clinical Trials

NCT01644968

preyes admin2 — Tue, 17 Jul 2012 16:49:00 +0000

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I

NCT01552681

preyes admin2 — Fri, 09 Mar 2012 23:55:00 +0000

Baminercept in Sjögren's Syndrome

Conditions: Sjögren's Syndrome
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase: II

NCT01516307

jensen admin2 — Thu, 19 Jan 2012 22:56:00 +0000

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

Conditions: Metastatic Breast Cancer
Sponsors: Optimer Biotechnology, Inc.
Phase II

NCT01509391

jensen admin2 — Mon, 09 Jan 2012 22:59:00 +0000

Keyhole Limpet Hemocyanin in Chronic Hepatitis C (IM1)

Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a

2011-004394-90

jensen admin2 — Mon, 09 Jan 2012 18:37:00 +0000

Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1

Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a

NCT01498328

jensen admin2 — Wed, 21 Dec 2011 22:54:00 +0000

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase II

NCT01489956

jensen admin2 — Thu, 01 Dec 2011 22:51:00 +0000

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase 0

NCT01480479

jensen admin2 — Mon, 21 Nov 2011 22:57:00 +0000

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase III

NCT01456104

jensen admin2 — Tue, 18 Oct 2011 23:57:00 +0000

Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma

Conditions: Melanoma
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I

Source: Clin Cancer Res April 1, 2011 17; 1984 (http://clincancerres.aacrjournals.org/content/17/7/1984.long)

NCT01426828

Administrator — Tue, 30 Aug 2011 22:15:00 +0000

Id-KLH Vaccine + T Cells

Conditions: Multiple Myeloma
Sponsors: Abramson Cancer Center of the University of Pennsylvania
Phase II